Pericoronary adipose tissue density a novel CT-derived marker of local inflammation and coronary artery disease in people living with HIV
冠状动脉周围脂肪组织密度是 HIV 感染者局部炎症和冠状动脉疾病的新型 CT 衍生标志物
基本信息
- 批准号:10762536
- 负责人:
- 金额:$ 43.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdipose tissueArterial Fatty StreakAtherosclerosisBiological MarkersBlood VesselsCardiacCardiovascular systemCharacteristicsCoronaryCoronary ArteriosclerosisCoronary arteryDataDevelopmentDistalEtiologyEventFatty acid glycerol estersFunctional ImagingGeneral PopulationGrantHIVHIV InfectionsImmuneInflammationInflammatoryInvestmentsMeasurementMeasuresMediatingMediationNatural HistoryParticipantPathogenesisPatientsPersonsPhenotypePlacebosPopulationPrevalencePrevention trialRandomizedRisk AssessmentRisk FactorsRisk ReductionRoleSiteTimeWorkX-Ray Computed Tomographyadverse event riskarmatherogenesiscardiovascular disorder preventioncardiovascular disorder riskcardiovascular risk factorcohortcoronary plaquecytokinedensitydisorder riskfluorodeoxyglucose positron emission tomographyhistological studiesimmune activationimprovedindexinginflammatory markerinflammatory milieunovelpreventrandomized trialrisk stratificationtreatment trialtrial designuptakevascular inflammation
项目摘要
PROJECT SUMMARY/ABSTRACT
People with HIV (PWH) have a heightened coronary artery disease (CAD) and adverse event risk even after
controlling for traditional cardiovascular (CV) risk factors. Hence, there is an unmet need for improved CV risk
stratification among PWH. HIV infection is associated with increased systemic immune activation and
inflammation that is not part of the traditional CV risk assessment. Importantly, work to date in PWH has been
limited to evaluating systemic inflammatory biomarkers or utilizing functional imaging assessments of vascular
inflammation at vessels larger than the coronary arteries. Assessing large vessels prevents direct assessment
of the local coronary inflammatory milieu that drives the development of coronary plaques. Nevertheless,
recent advances in cardiac computed tomography (CT), specifically assessing the density of peri-coronary
adipose tissue (PCAT) that directly surrounds the coronary arteries, suggest that PCAT density may be an
accurate non-invasive index of coronary artery inflammation. In the proposed study, we will leverage data
obtained from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), in which we have shown
high rates of vulnerable plaque, in association with key systemic inflammatory markers, among asymptomatic
PWH on ART, with only low to moderate traditional atherosclerotic cardiovascular disease (ASCVD) risk. We
will first assess the relationship of coronary inflammation to critical cardiac CT and deep immune phenotyping
parameters, including noncalcified plaque volume, obtained in the mechanistic substudy of REPRIEVE. We will
further leverage the trial design, encompassing a randomized treatment trial of statin therapy and serial
assessments of CTA parameters to assess the natural history of coronary inflammation and plaque and the
key effects of statin therapy in PWH. Specifically, we will analyze the unique relation of coronary inflammation,
measured as PCAT density, to coronary plaque development and changes in plaque composition in
relationship to other CV risk factors, the effects of statins on coronary inflammation in relation to changes in
plaque volume, and the relationship to MACE in exploratory analyses. Successful completion of this study will
inform the field of the critical, independent role of coronary inflammation in the development of coronary plaque
in PWH and determine for the first time whether a reduction in coronary inflammation contributes to statin-
related effects on plaque parameters in this population. Data from this grant, leveraging a key ASCVD
prevention trial, will thus inform the development of more targeted CV risk reduction strategies among PWH.
项目总结/摘要
HIV感染者(PWH)即使在治疗后也有较高的冠状动脉疾病(CAD)和不良事件风险。
控制传统的心血管(CV)风险因素。因此,改善CV风险的需求尚未得到满足
威尔斯亲王医院分层。HIV感染与增加的全身免疫激活有关,
炎症不是传统CV风险评估的一部分。重要的是,到目前为止,威尔斯亲王医院的工作
仅限于评价全身炎症生物标志物或利用血管功能成像评估
比冠状动脉大的血管的炎症。评估大型船舶妨碍直接评估
局部冠状动脉炎症环境的影响,导致冠状动脉斑块的发展。但是,尽管如此,
心脏计算机断层扫描(CT)的最新进展,特别是评估冠状动脉周围的密度
直接围绕冠状动脉的脂肪组织(PCAT),表明PCAT密度可能是一个
准确的冠状动脉炎症无创指数。在拟议的研究中,我们将利用数据
从随机试验中获得,以防止艾滋病毒血管事件(REPRIEVE),其中我们已经表明,
在无症状人群中,易损斑块的发生率较高,与关键的全身炎症标志物相关
接受ART的PWH,仅具有低至中度传统动脉粥样硬化性心血管疾病(ASCVD)风险。我们
将首先评估冠状动脉炎症与关键心脏CT和深层免疫表型的关系
REPRIEVE机制子研究中获得的参数,包括非钙化斑块体积。我们将
进一步利用试验设计,包括他汀类药物治疗的随机治疗试验和
评估CTA参数,以评估冠状动脉炎症和斑块的自然史,
他汀类药物治疗PWH的关键作用。具体来说,我们将分析冠状动脉炎症的独特关系,
测量为PCAT密度,冠状动脉斑块的发展和斑块组成的变化,
与其他CV风险因素的关系,他汀类药物对冠状动脉炎症的影响与
探索性分析中的斑块体积以及与MACE的关系。成功完成本研究将
告知该领域冠状动脉炎症在冠状动脉斑块发展中的关键、独立作用
并首次确定冠状动脉炎症的减少是否有助于他汀类药物-
对该人群斑块参数的相关影响。来自该补助金的数据,利用关键的ASCVD
因此,预防试验将为威尔斯亲王医院制定更有针对性的降低心血管风险策略提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Borek Foldyna其他文献
Borek Foldyna的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Research Grant